Literature DB >> 10094259

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

P Sarchielli1, O Presciutti, G P Pelliccioli, R Tarducci, G Gobbi, P Chiarini, A Alberti, F Vicinanza, V Gallai.   

Abstract

The aim of this research was to obtain an absolute quantification of the N-acetyl-aspartate, choline, creatine and phosphocreatine levels in normal-appearing white matter by means of 1H magnetic resonance spectroscopy in a group of multiple sclerosis patients (27 with the relapsing-remitting form and 13 with the secondary progressive form). These values were compared with those of a group of 12 age-matched healthy control subjects. A significant decrease in the N-acetyl-aspartate concentration was found in normal-appearing white matter of frontal and parietal brain areas in multiple sclerosis patients compared with the same areas in control subjects. This reduction was more evident in progressive patients. The decrease in the N-acetyl-aspartate concentration in normal-appearing white matter significantly correlated with the Expanded Disability Status and the lesional load. No significant change was found in the concentration of creatine or choline. This finding concurs with previous evidence of heterogeneity in the multiple sclerosis pathological process which is not confined to the lesions and involves not only myelin, but also axons, even in white matter which appears normal on MRI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094259     DOI: 10.1093/brain/122.3.513

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  27 in total

Review 1.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 2.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Authors:  Ivan I Kirov; Songtao Liu; Roman Fleysher; Lazar Fleysher; James S Babb; Joseph Herbert; Oded Gonen
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

4.  1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.

Authors:  J Suhy; W D Rooney; D E Goodkin; A A Capizzano; B J Soher; A A Maudsley; E Waubant; P B Andersson; M W Weiner
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

Review 5.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 6.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

7.  Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.

Authors:  Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

8.  Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability.

Authors:  S Temel; H D Keklikoğlu; H D Kekliğkoğlu; G Vural; O Deniz; K Ercan
Journal:  Neuroradiol J       Date:  2013-03-08

9.  Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.

Authors:  Fahmy Aboul-Enein; Martin Krssák; Romana Höftberger; Daniela Prayer; Wolfgang Kristoferitsch
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

10.  Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.

Authors:  M C Gustafsson; O Dahlqvist; J Jaworski; P Lundberg; A-M E Landtblom
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.